NCT00027573View on ClinicalTrials.gov

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

cyclophosphamide

DRUG

fludarabine phosphate

DRUG

methotrexate

DRUG

tacrolimus

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (6)

55905

Mayo Clinic Cancer Center, Rochester

74136

CCOP - Oklahoma, Tulsa

85259-5404

CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale

46202-5289

Indiana University Cancer Center, Indianapolis

02215

Beth Israel Deaconess Medical Center, Boston

07601

CCOP - Northern New Jersey, Hackensack

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00027573 - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer | Biotech Hunter | Biotech Hunter